SENTAN Pharma Begins Farm Trials of "High Gamma Oryzanol" Nano-Feed to Improve Livestock Efficiency
SENTAN Pharma has started farm trials of "High Gamma Oryzanol," a next-generation nano-feed ingredient utilizing its unique micro-particulation platform technology, aiming to improve livestock efficiency and reduce environmental impact for sustainable farming.
📋 Article Processing Timeline
- 📰 Published: May 12, 2026 at 19:00
- 🔍 Collected: May 12, 2026 at 10:31
- 🤖 AI Analyzed: May 14, 2026 at 06:55 (44h 24m after Collected)
SENTAN Pharma Inc. (Fukuoka, Fukuoka Prefecture, Representative Director Masahiro Matsubara) announces the commencement of field tests in pig and broiler farms for "High Gamma Oryzanol," a next-generation nano-feed ingredient being developed using its unique micro-particulation platform technology.
Challenges Facing the Livestock Industry
The livestock industry is a vital sector supporting food supply, but it faces numerous challenges, including "rising feed prices," "improving production efficiency," "environmental impact from livestock farming," and "livestock shed odor issues." Feed costs, in particular, constitute a significant portion of livestock farm management, making improvements in feed efficiency (Feed Conversion Ratio) a critical theme from the perspective of enhancing productivity and resource utilization efficiency. Moreover, improving feed efficiency is expected not only to boost the profitability of livestock farming but also to contribute to the effective global utilization of feed resources. Furthermore, reducing livestock-derived odors and environmental impact is one of the crucial societal challenges for achieving sustainable livestock farming.
Expectations for "High Gamma Oryzanol"
SENTAN Pharma is advancing research to apply naturally derived ingredients as feed materials, leveraging its micro-particulation (nano-ization) technology cultivated in the pharmaceutical and food sectors. "High Gamma Oryzanol," currently under development, is a feed ingredient created by nano-particulating rice bran-derived components using our company's micro-particulation platform technology. Nano-ization is expected to improve ingredient dispersibility and utilization efficiency, and research is ongoing regarding its impact on the following indicators in the livestock sector. This product is in the prototype stage, and demonstration tests are being conducted in pig and broiler farms. We are continuously collecting data in real farm environments to build evidence.
* Changes in Feed Conversion Ratio
* Changes in Rearing Rate
* Changes in Weight Gain
* Indicators related to reduction of fecal odor
Joint Project with Nippon Soda Co., Ltd.
This initiative is progressing as a joint project with Nippon Soda Co., Ltd. (capital and business alliance in 2024). Going forward, we are considering commercialization, including expansion into domestic and international markets, by utilizing their sales network in the livestock sector.
Future Developments
This initiative is an R&D project combining "naturally derived ingredients x nano technology x livestock." It has the potential to optimize resource utilization through improved feed efficiency and enhance the livestock environment, advancing research as a new approach to achieving sustainable livestock farming. In addition to the ongoing field tests in pig and broiler farms, we plan to expand field tests to cattle (beef and dairy) in the future, thereby verifying the technology across a wider range of livestock. Our company aims to create new industrial domains by deploying the technology cultivated in the pharmaceutical sector to the agriculture and livestock sectors, utilizing our micro-particulation platform.
Inquiries about Handling
For inquiries regarding handling, please contact us at the email address below.
hm@sentan.co.jp
About SENTAN Pharma Inc.
SENTAN Pharma utilizes its proprietary nano/micro-particulation fundamental technology, the "SENTAN Platform," to develop business in a wide range of fields, including pharmaceuticals, health foods like "Genmai Foodicle," and livestock/aquaculture feeds such as "High Gamma Oryzanol," aiming to improve the social environment through micro-particulation.
https://www.sentan.co.jp/
Challenges Facing the Livestock Industry
The livestock industry is a vital sector supporting food supply, but it faces numerous challenges, including "rising feed prices," "improving production efficiency," "environmental impact from livestock farming," and "livestock shed odor issues." Feed costs, in particular, constitute a significant portion of livestock farm management, making improvements in feed efficiency (Feed Conversion Ratio) a critical theme from the perspective of enhancing productivity and resource utilization efficiency. Moreover, improving feed efficiency is expected not only to boost the profitability of livestock farming but also to contribute to the effective global utilization of feed resources. Furthermore, reducing livestock-derived odors and environmental impact is one of the crucial societal challenges for achieving sustainable livestock farming.
Expectations for "High Gamma Oryzanol"
SENTAN Pharma is advancing research to apply naturally derived ingredients as feed materials, leveraging its micro-particulation (nano-ization) technology cultivated in the pharmaceutical and food sectors. "High Gamma Oryzanol," currently under development, is a feed ingredient created by nano-particulating rice bran-derived components using our company's micro-particulation platform technology. Nano-ization is expected to improve ingredient dispersibility and utilization efficiency, and research is ongoing regarding its impact on the following indicators in the livestock sector. This product is in the prototype stage, and demonstration tests are being conducted in pig and broiler farms. We are continuously collecting data in real farm environments to build evidence.
* Changes in Feed Conversion Ratio
* Changes in Rearing Rate
* Changes in Weight Gain
* Indicators related to reduction of fecal odor
Joint Project with Nippon Soda Co., Ltd.
This initiative is progressing as a joint project with Nippon Soda Co., Ltd. (capital and business alliance in 2024). Going forward, we are considering commercialization, including expansion into domestic and international markets, by utilizing their sales network in the livestock sector.
Future Developments
This initiative is an R&D project combining "naturally derived ingredients x nano technology x livestock." It has the potential to optimize resource utilization through improved feed efficiency and enhance the livestock environment, advancing research as a new approach to achieving sustainable livestock farming. In addition to the ongoing field tests in pig and broiler farms, we plan to expand field tests to cattle (beef and dairy) in the future, thereby verifying the technology across a wider range of livestock. Our company aims to create new industrial domains by deploying the technology cultivated in the pharmaceutical sector to the agriculture and livestock sectors, utilizing our micro-particulation platform.
Inquiries about Handling
For inquiries regarding handling, please contact us at the email address below.
hm@sentan.co.jp
About SENTAN Pharma Inc.
SENTAN Pharma utilizes its proprietary nano/micro-particulation fundamental technology, the "SENTAN Platform," to develop business in a wide range of fields, including pharmaceuticals, health foods like "Genmai Foodicle," and livestock/aquaculture feeds such as "High Gamma Oryzanol," aiming to improve the social environment through micro-particulation.
https://www.sentan.co.jp/